Chapter 4 Clinical MRI Mapping

2021 ◽  
pp. 125-134
Keyword(s):  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Johanna Habermeyer ◽  
Janina Boyken ◽  
Julia Harrer ◽  
Fabio Canneva ◽  
Veronika Ratz ◽  
...  

AbstractGadolinium based contrast agents (GBCAs) are widely used in clinical MRI since the mid-1980s. Recently, concerns have been raised that trace amounts of Gadolinium (Gd), detected in brains even long time after GBCA application, may cause yet unrecognized clinical consequences. We therefore assessed the behavioral phenotype, neuro-histopathology, and Gd localization after repeated administration of linear (gadodiamide) or macrocyclic (gadobutrol) GBCA in rats. While most behavioral tests revealed no difference between treatment groups, we observed a transient and reversible decrease of the startle reflex after gadodiamide application. Residual Gd in the lateral cerebellar nucleus was neither associated with a general gene expression pathway deregulation nor with neuronal cell loss, but in gadodiamide-treated rats Gd was associated with the perineuronal net protein aggrecan and segregated to high molecular weight fractions. Our behavioral finding together with Gd distribution and speciation support a substance class difference for Gd presence in the brain after GBCA application.


2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Judith E. Spiro ◽  
Miriam Rinneburger ◽  
Dennis M. Hedderich ◽  
Mladen Jokic ◽  
Hans Christian Reinhardt ◽  
...  

2019 ◽  
Vol 266 (10) ◽  
pp. 2488-2494 ◽  
Author(s):  
Julia Zimmermann ◽  
Sarah Jesse ◽  
Jan Kassubek ◽  
Elmar Pinkhardt ◽  
Albert C. Ludolph

Author(s):  
M.A. van Buchem ◽  
J. van der Grond ◽  
M. Versluis ◽  
M.J.P. van Osch ◽  
W. Teeuwisse ◽  
...  
Keyword(s):  

2016 ◽  
Vol 12 ◽  
pp. P518-P518
Author(s):  
Xiaowei Song ◽  
Hui Guo ◽  
Ryan C.N. D'Arcy ◽  
William Siu ◽  
John Diggle ◽  
...  

Author(s):  
Leonardo Bibbiani ◽  
Sara Canal ◽  
Daiana Marabese ◽  
Maria T. Mandara ◽  
Greta Foiani ◽  
...  

ABSTRACT Human hypothalamic neuronal hamartomas are rare, nonprogressive, congenital malformations of the hypothalamus that do not expand or metastasize to other locations. A 1 yr old female vizsla was presented for progressive intracranial multifocal neurological signs already present since adoption at 3 mo of age. MRI of the brain showed an ill-defined, intra-axial, space-occupying, nonenhancing lesion located in the ventral middle cranial fossa. Histopathological examination was consistent with hypothalamic neuronal hamartoma. This is the first report describing clinical, imaging, and histopathological features of a hypothalamic neuronal hamartoma in a dog. These findings are compared with the human counterparts.


2018 ◽  
Vol 63 (6) ◽  
pp. 065008 ◽  
Author(s):  
Calum Crake ◽  
Spencer T Brinker ◽  
Christian M Coviello ◽  
Margaret S Livingstone ◽  
Nathan J McDannold

2015 ◽  
Vol 76 (5) ◽  
pp. 1636-1641 ◽  
Author(s):  
Martin Meyerspeer ◽  
Arthur W. Magill ◽  
Andre Kuehne ◽  
Rolf Gruetter ◽  
Ewald Moser ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document